Prevention of stress-induced damage in experimental animals and livestock by monomagnesium-L-aspartate hydrochloride.
Monomagnesium-L-aspartate hydrochloride (Mg-Asp. HCl) is readily absorbed from the intestine of rats because this process is not saturable. Depending upon the dose administered, Mg-Asp. HCl exhibits Ca-antagonistic effects and inhibits the release of stress hormones. Higher concentrations of Mg salts, which do not contain chloride, e.g. MgO, tend to induce hypochloremic, metabolic alkalosis and changes of urinary pH, whereas MgCl2 produces hyperchloremic acidosis under these conditions. Evidence is given that oral supplementation with Mg-Asp. HCl has beneficial effects not only in experimental animals or livestock, but also in man, e.g. on exposure to muscular stress.
D000136:Acid-Base Equilibrium; D000471:Alkalosis / Q000139:chemically induced; D000818:Animals; D001224:Aspartic Acid / Q000494:pharmacology*; D002712:Chlorides / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000008:administration & dosage / Q000627:therapeutic use*; D008277:Magnesium Oxide / Q000009:adverse effects; D013312:Stress, Physiological / Q000628:therapy*; D014556:Urine / Q000502:physiology
D002712:Chlorides; D001224:Aspartic Acid; D008277:Magnesium Oxide; D008274:Magnesium